HALO short interest
Halozyme Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 15,295,841 |
|---|---|
| Change vs prior report | 141,427 (+0.9%) |
| Change over six months | +8.9% |
| Days to cover | 4.54 (sector: 3.78) |
| Average daily volume | 3,366,912 |
| Rank in Healthcare | #459 of 922 by days to cover |
HALO short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 15,295,841 | +0.9% | 4.54 | 3,366,912 |
| 2026-09-15 | 15,154,414 | +1.8% | 11.59 | 1,307,689 |
| 2026-08-31 | 14,880,707 | +1.7% | 8.69 | 1,712,268 |
| 2026-08-14 | 14,636,927 | +4.4% | 5.01 | 2,919,803 |
| 2026-07-31 | 14,022,134 | +5.5% | 8.35 | 1,679,119 |
| 2026-07-15 | 13,295,961 | +0.5% | 7.27 | 1,828,707 |
| 2026-06-30 | 13,226,223 | +2.1% | 6.27 | 2,108,787 |
| 2026-06-15 | 12,948,289 | -5.1% | 7.84 | 1,652,526 |
| 2026-05-29 | 13,644,245 | +1.9% | 8.12 | 1,680,327 |
| 2026-05-15 | 13,389,887 | -6.9% | 6.72 | 1,991,771 |
| 2026-04-30 | 14,381,741 | +0.9% | 10.22 | 1,407,549 |
| 2026-04-15 | 14,257,845 | +1.5% | 10.57 | 1,348,999 |
| 2026-03-31 | 14,046,350 | +2.5% | 9.41 | 1,493,288 |
| 2026-03-13 | 13,701,015 | +1.5% | 8.40 | 1,630,424 |
| 2026-02-27 | 13,498,344 | -2.1% | 6.14 | 2,199,321 |
| 2026-02-13 | 13,795,570 | +2.1% | 6.46 | 2,134,102 |
| 2026-01-30 | 13,515,827 | -0.6% | 9.07 | 1,490,869 |
| 2026-01-15 | 13,593,503 | -1.5% | 6.10 | 2,227,816 |
| 2025-12-31 | 13,800,472 | +10.4% | 9.89 | 1,395,958 |
| 2025-12-15 | 12,500,858 | +1.0% | 4.44 | 2,816,317 |
| 2025-11-28 | 12,372,896 | -0.8% | 6.06 | 2,042,714 |
| 2025-11-14 | 12,479,411 | +10.4% | 3.91 | 3,188,411 |
| 2025-10-31 | 11,305,141 | -1.8% | 7.65 | 1,477,599 |
| 2025-10-15 | 11,510,110 | +6.6% | 4.80 | 2,398,287 |
| 2025-09-30 | 10,797,290 | -8.3% | 4.89 | 2,208,182 |
import finzdata as yf
yf.Ticker("HALO").short_interest # every report since 2017
yf.Client().short_interest(["HALO"], start="2018-01-01")Healthcare short interest · HALO price history · Who owns HALO · All short interest